Table 1 Baseline Characteristics of Study Cohort
Characteristics | Overall (n = 176) | Total Cohort (n = 176) | ||
|---|---|---|---|---|
< 70 years (n = 121) | ≧70 years (n = 55) | p Value | ||
Age, median (IQR), years | 65 (56–71) | 60 (50.5–65) | 76(72–78) | < 0.0001 |
Male | 124 (70.5) | 92 (76.0) | 32 (58.2) | 0.0206 |
Body mass index, mean (SD) | 22.4 (3.8) | 23.4 (3.8) | 20.3 (2.9) | < 0.0001 |
Body surface area, mean (SD), m2 | 1.59 (0.22) | 1.67 (0.19) | 1.43 (0.16) | < 0.0001 |
Diabetes mellitus | 18 (10.2) | 12 (9.9) | 6 (10.9) | 0.7953 |
Dyslipidemia | 60 (34.1) | 40 (33.1) | 20 (36.4) | 0.7323 |
Hypertension | 94 (53.4) | 59 (48.8) | 35 (63.6) | 0.0746 |
Chronic lung disease | 6 (3.4) | 2 (1.7) | 4 (7.2) | 0.0773 |
Chronic renal failure | 3 (1.7) | 1 (0.8) | 2 (3.6) | 0.2305 |
Peripheral vascular disease | 7 (4.0) | 4 (3.3) | 3 (5.5) | 0.6685 |
Cerebrovascular disease | 5 (2.8) | 1 (0.8) | 4 (7.3) | 0.0337 |
History of heart failure | 45 (25.6) | 26 (21.5) | 19 (34.5) | 0.0925 |
Atrial fibrillation | 71 (40.3) | 45 (37.2) | 26 (47.3) | 0.2465 |
Chronic | 46 (26.1) | 26 (21.5) | 20 (36.4) | 0.0431 |
Paroxysmal | 25 (14.2) | 19 (15.7) | 6 (10.9) | 0.4891 |
Previous myocardial infarction | 4 (2.3) | 2 (1.7) | 2 (3.6) | 0.5900 |
EF, median (IQR) | 59 (55–61) | 58 (55–60) | 60 (53–62) | 0.4023 |
Coronary artery disease | 21 (11.9) | 11 (9.1) | 10 (18.2) | 0.1298 |
NYHA functional class III-IV | 88(50.0) | 55(45.5) | 33(60.0) | 0.1842 |
MR grade | 0.7291 | |||
moderate | 66(37.5) | 47(38.8) | 19(34.5) | |
severe | 110(62.5) | 74(61.2) | 36(65.5) | |
EuroSCORE II, median (IQR), % | 1.4(0.9–2.3) | 1.1(0.8–1.6) | 2.4(1.7–4.2) | < 0.0001 |